SCHEMBL4820451

SCHEMBL4820451

Brc1c2ccccc2c(-c2ccc(/C=C/c3ccccc3)cc2)c2ccccc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 3/20 0.42
NFE2L2 Q16236 1/20 0.42
CYP19A1 P11511 1/20 0.42
MAOA P21397 1/20 0.42
HDAC1 Q13547 1/20 0.39
RELA Q04206 2/20 0.38
TRPA1 O75762 1/20 0.38
HDAC2 Q92769 1/20 0.37
KDM4E B2RXH2 1/20 0.37
MAPT P10636 1/20 0.37
MAPK1 P28482 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
CA1 P00915 1/20 0.36
MGLL Q99685 1/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4820453 1.00 MAOB (0.42) MAOBNFE2L2CYP19A1MAOAHDAC1
SCHEMBL3381117 0.84 CA1 (0.50) MAOBNFE2L2CYP19A1MAOAHDAC1
SCHEMBL1884281 0.84 CA1 (0.50) MAOBNFE2L2CYP19A1MAOAHDAC1
SCHEMBL1884278 0.84 CA1 (0.50) MAOBNFE2L2CYP19A1MAOAHDAC1
SCHEMBL12560663 0.83 MAPK1 (0.48) KDM4EMAPTMAPK1TDP1L3MBTL1
SCHEMBL3000291 0.83 KDM4E (0.42) KDM4EMAPTMAPK1TDP1L3MBTL1
SCHEMBL16657337 0.82 HDAC8 (0.47) CA1CHAT
SCHEMBL12560730 0.81 MAPK1 (0.50) RELAKDM4EMAPTMAPK1TDP1
SCHEMBL29603166 0.81 MAPK1 (0.50) RELAKDM4EMAPTMAPK1TDP1
SCHEMBL1534946 0.81 MAPK1 (0.50) RELAKDM4EMAPTMAPK1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080193799-A1 Organic electroluminescence device IDEMITSU KOSAN CO., LTD. (JP) 2008-08-14 US disclosed
US-7361796-B2 Orangic electroluminescence device IDEMITSU KOSAN CO., LTD. (JP) 2008-04-22 US disclosed
US-7053255-B2 Substituted diphenylanthracene compounds for organic electroluminescence devices IDEMITSU KOSAN CO., LTD. (JP) 2006-05-30 US disclosed
US-20060083947-A1 Organic electroluminescence device IDEMITSU KOSAN CO., LTD. (JP) 2006-04-20 US disclosed
US-20040214035-A1 Organic electroluminescence device IDEMITSU KOSAN CO., LTD. 2004-10-28 US disclosed
EP-1333018-A1 ORGANIC ELECTROLUMINESCENT ELEMENT IDEMITSU KOSAN CO., LTD. (JP) 2003-08-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080193799-A1 Organic electroluminescence device EED, KCNH2, DCX MAOB 371/4885NFE2L2 181/4885CYP19A1 2017/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.